1. U.S. Pain Management Pharmaceutical Markets The Emergence Of New Therapeutic Categories Drives Growth “ The Pain Management Pharmaceuticals Markets scenario has undergone a revolution with the entry of the selective COX-2 inhibitors amongst NSAIDs, the arrival of the Triptans as Anti-Migraine Drugs and introduction of new dosage forms in the Opioid Analgesics ” HealthCare Analyst Team Frost & Sullivan

2. Mergers and acquisitions for domination in the pain management pharmaceuticals market Incorporation of companies exclusively devoted to research, manufacturing and marketing of pain management pharmaceuticals Widened end-user base through co-marketing with larger combined sales teams and increased market penetration Research and development activities in abuse-resistant opioid formulations Research and development activities in longer-acting transdermal drug delivery systems for opioids Direct to consumer marketing, earlier used extensively by OTC products, on the rise even for prescription pain management products Industry Trends

3. Frost & Sullivan provides: Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analyst insights on ‘hot topics” and emerging products in the Pain Management Pharmaceuticals Markets Market sizing and competitive analysis Market forecasts and opportunity analysis End user analysis within each report Key Features

4. Coverage of the U.S. Pain Management Pharmaceuticals Markets Proven methodology encompassing extensive primary and secondary data and research Focused information and strategies that cover business and technology issues Credible data and analysis highlighting industry dynamics Winning strategies to help you create precise business plans What We Offer

5. Current Market Participants Find out how you compare to the competition Assess current and future drivers and restraints Determine and exploit new market share opportunities New Entrants Analyze challenges associated with the industry Calculate time scales for strategy implementation Position yourself to capitalize on the market’s unmet needs Investment Community Analyze long-term strategies of companies in pain management pharmaceuticals market Determine which participants will outperform the competition Assess attractiveness of investing in pain management pharmaceuticals market Who Will Benefit?

6.  Total Pain Management Pharmaceuticals Markets  Non-Opioid Analgesics Market  Opioid Analgesics Market  Non-Steroidal Anti-Inflammatory Drugs Market  Anti-Migraine Drugs Market What’s Included

7. Abbott Laboratories, Inc. Adolar Corp. Allergan, Inc. Anesta Corp. Astra Zeneca. Bristol-Myers Squibb Co. Celltech Chirosciences Ltd. CeNeS Pharmaceuticals plc. Elan Corporation PLC. Endo Pharmaceuticals Holdings, Inc. EpiCept Corp. Glaxo SmithKline GW Pharmaceuticals Ltd. NicOx SA. Merck & Co., Inc. Novartis AG. NPS Pharmaceuticals, Inc. Pain Therapeutics, Inc.(PTI) Pfizer, Inc. Purdue Pharmaceuticals LP Key Market Participants

8. Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 Email myfrost@frost.com Visit www.frost.com For More Information